本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
Iron Triangle Partners LP (CIK 1779763) reported $874.7M across 27 reported positions in its SEC 13F filing for 2025-12-31. Largest positions: CRL ($75.7M, 8.66%), ISRG ($53.5M, 6.12%), RGEN ($52.5M, 6.00%), JAZZ ($49.7M, 5.68%), VCYT ($41.3M, 4.72%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CRL | CHARLES RIV LABS INTL INC | $75.7M | 8.66% | 379,728 | Added |
| 2 | ISRG | INTUITIVE SURGICAL INC | $53.5M | 6.12% | 94,459 | New |
| 3 | RGEN | REPLIGEN CORP | $52.5M | 6.00% | 320,474 | Added |
| 4 | JAZZ | JAZZ PHARMACEUTICALS PLC | $49.7M | 5.68% | 292,170 | Added |
| 5 | VCYT | VERACYTE INC | $41.3M | 4.72% | 980,391 | Added |
| 6 | BSX | BOSTON SCIENTIFIC CORP | $40.1M | 4.59% | 420,773 | New |
| 7 | WAT | WATERS CORP | $39.9M | 4.57% | 105,167 | New |
| 8 | BKD | BROOKDALE SR LIVING INC | $37.7M | 4.31% | 3.5M | Added |
| 9 | LLY | ELI LILLY & CO | $37.7M | 4.31% | 35,045 | Trimmed |
| 10 | BRKR | BRUKER CORP | $37.4M | 4.28% | 794,380 | New |
| 11 | VRTX | VERTEX PHARMACEUTICALS INC | $34.9M | 3.99% | 76,910 | New |
| 12 | CVS | CVS HEALTH CORP | $34.3M | 3.92% | 432,457 | Trimmed |
| 13 | FTRE | FORTREA HLDGS INC | $34.3M | 3.92% | 2.0M | New |
| 14 | MMSI | MERIT MED SYS INC | $34.0M | 3.89% | 385,660 | New |
| 15 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $33.6M | 3.84% | 897,427 | Trimmed |
| 16 | DOCS | DOXIMITY INC | $30.4M | 3.48% | 686,568 | Added |
| 17 | TECH | BIO-TECHNE CORP | $27.5M | 3.14% | 467,409 | New |
| 18 | ATEC | ALPHATEC HLDGS INC | $27.1M | 3.09% | 1.3M | New |
| 19 | AHCO | ADAPTHEALTH CORP | $26.0M | 2.97% | 2.6M | Added |
| 20 | NVST | ENVISTA HOLDINGS CORPORATION | $25.8M | 2.95% | 1.2M | New |
| 21 | UNH | UNITEDHEALTH GROUP INC | $23.1M | 2.65% | 70,126 | New |
| 22 | ABT | ABBOTT LABS | $22.0M | 2.51% | 175,333 | New |
| 23 | IDYA | IDEAYA BIOSCIENCES INC | $16.2M | 1.85% | 467,484 | Added |
| 24 | BHVN | BIOHAVEN LTD | $10.8M | 1.24% | 958,336 | New |
| 25 | XENE | XENON PHARMACEUTICALS INC | $10.5M | 1.20% | 233,688 | New |
来源：SEC 13F 申报文件 · 截至 2025-12-31